By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Valeant Pharmaceuticals International 

Worldwide Headquarters
One Enterprise
Aliso Viejo  California  92656  U.S.A.
Phone: 800-548-5100 or 949-461-6000 Fax: 714-556-0131




Metabasis Therapeutics, Inc.  – Hepatitis B

Company News
Redemption Of All Of Salix (SLXP)'s Outstanding 6.00% Senior Notes Due 2021 4/1/2015 9:35:08 AM
Valeant (VRX) Completes Acquisition Of Salix (SLXP) 4/1/2015 8:38:33 AM
Valeant (VRX) Completes Tender Offer For Salix (SLXP) 4/1/2015 6:03:48 AM
Valeant (VRX) Closes Offering Of $1.45 Billion Of Common Shares 3/27/2015 9:31:34 AM
Valeant (VRX) Announces Offering Of $1.45 Billion Of Common Shares 3/17/2015 9:56:09 AM
Valeant (VRX) Prices Offering Of $1.45 Billion Of Common Shares 3/17/2015 7:30:43 AM
Valeant (VRX) Announces HSR Clearance For Salix (SLXP) Acquisition 3/16/2015 6:37:33 AM
Valeant (VRX) Sweetens Salix (SLXP) Deal to $173 Per Share After Teaming Up With Ackman and Endo International (ENDP) Withdraws 3/16/2015 6:06:20 AM
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 3/13/2015 7:47:44 AM
Valeant (VRX) Release: Three New CeraVe Baby Products Awarded National Eczema Association (NEA) Seal Of Acceptance 3/12/2015 11:16:45 AM